雜志介紹

European Journal Of Clinical Pharmacology雜志介紹

《European Journal Of Clinical Pharmacology》是一本以English為主的未開放獲取國際優(yōu)秀期刊，中文名稱歐洲臨床藥理學(xué)雜志，本刊主要出版、報道醫(yī)學(xué)-PHARMACOLOGY & PHARMACY領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為2.4，最新CiteScore 指數(shù)為5.4。

本刊近期中國學(xué)者發(fā)表的論文主要有：

• The pharmacokinetics and safety of lidocaine in liver cancer patients undergoing hepatic resection

  Author: He, Chaoqun; Jin, Ying; Zhang, Yang; Zhang, Mengyu; Di, Xiangjie; Fu, Lisha; Qi, Xiaohui; Liu, Runhan; Zheng, Li; Wang, Zhenlei; Li, Jingdong; Tu, Faping

• Does aspirin reduce the incidence, recurrence, and mortality of hepatocellular carcinoma? A GRADE-assessed systematic review and dose-response meta-analysis

  Author: Ma, Shaodi; Qu, Guangbo; Sun, Chenyu; Liu, Haixia; Jiang, Yuemeng; Li, Ning; Wu, Birong; Gao, Juan; Feng, Linya; Xie, Peng; Xia, Weihang; Kim, Na Hyun; Lowe, Scott; Bentley, Rachel; Zhu, Yike; Zhou, Qin; Sun, Yehuan

• Antiplatelet therapy for secondary prevention of lacunar stroke: a systematic review and network meta-analysis

  Author: Hou, Xiaowen; Cen, Kaiwen; Cui, Ying; Zhang, Yuhong; Feng, Xu

• The risk of congenital heart defects associated with corticosteroids use during the first trimester of pregnancy: a systematic review and meta-analysis

  Author: Wei, Jiehua; Xia, Fan; Miao, Junxiang; Wang, Tingting; Chen, Lizhang; Yan, Xuemei

英文介紹

European Journal Of Clinical Pharmacology雜志英文介紹

The European Journal of Clinical Pharmacology publishes original papers on all aspects of clinical pharmacology and drug therapy in humans. Manuscripts are welcomed on the following topics: therapeutic trials, pharmacokinetics/pharmacodynamics, pharmacogenetics, drug metabolism, adverse drug reactions, drug interactions, all aspects of drug development, development relating to teaching in clinical pharmacology, pharmacoepidemiology, and matters relating to the rational prescribing and safe use of drugs. Methodological contributions relevant to these topics are also welcomed.

Data from animal experiments are accepted only in the context of original data in man reported in the same paper. EJCP will only consider manuscripts describing the frequency of allelic variants in different populations if this information is linked to functional data or new interesting variants. Highly relevant differences in frequency with a major impact in drug therapy for the respective population may be submitted as a letter to the editor.

Straightforward phase I pharmacokinetic or pharmacodynamic studies as parts of new drug development will only be considered for publication if the paper involves

-a compound that is interesting and new in some basic or fundamental way, or

-methods that are original in some basic sense, or

-a highly unexpected outcome, or

-conclusions that are scientifically novel in some basic or fundamental sense.